European Commission logo
français français
CORDIS - Résultats de la recherche de l’UE
CORDIS

Injection Moulding Repurposing for Medical Supplies enabled by Additive Manufacturing

Description du projet

Du plastique commercial aux fournitures médicales: reconversion rapide des capacités de fabrication

La pandémie actuelle a mis en évidence ce que les parties prenantes autour du globe savent depuis longtemps: retarder les mesures d’atténuation des risques de seulement quelques jours ou de quelques semaines peut avoir un impact significatif sur notre capacité à contenir un risque biologique et à protéger la santé publique et économique ainsi que le bien-être des citoyens. En outre, cette récente expérience a révélé notre incapacité à reconvertir rapidement des installations pour produire des équipements et des dotations médicaux vitaux. Le projet imPURE, financé par l’UE à travers la collaboration de 19 partenaires, entend développer la capacité de l’UE à permettre aux centres de moulage par injection de produire des équipements médicaux grâce à la fabrication additive, sous 48 heures, en concevant rapidement des moules modulaires avec des inserts interchangeables, tout en tenant compte des potentielles perturbations des chaînes d’approvisionnement.

Objectif

The modern world is fast-evolving, interconnected and highly mobile, thus posing a significant challenge in harmonizing risk mitigation measures against emerging biological hazards. For many years the risk of emerging infectious diseases with pandemic potential was declared a major threat to global health security and addressed by many stakeholders around the world. The delay in imposing risk mitigation measures is crucial and can make the difference between a local outbreak with few cases to a pandemic with countless sick and deceased citizens, as severely demonstrated by the recent outbreak of Coronavirus disease 2019 (COVID-19). It is of paramount importance that appropriate and proportionate measures to each phase of the pandemic (e.g. from situations with no reported cases, sporadic, local clusters of cases, to widespread sustained transmission) are immediately implemented to interrupt human-to-human transmission chains, prevent further spread and reduce the intensity of COVID-19 outbreak. Immediate activation of national emergency response mechanisms and pandemic preparedness plans to ensure containment and mitigation of COVID-19 with non-pharmaceutical public health measures is critical for delaying transmission or decreasing the peak of the outbreak, in order to allow healthcare systems to prepare and cope with an increased influx of patients. However, shortages and other gaps in the global medical supply chain represent a mismatch of supply and demand when supply is low and/or demand is high for particular items. With healthcare workers and other first responders feeling the impact of supply chains disrupted by unprecedented challenges, many large and small businesses from outside the traditional healthcare procurement system are reconfiguring to mass produce critical medical consumables. In order to address supply shortages, particularly in medical supplies and protective equipment, some countries have employed less traditional instruments.

Mots‑clés

Appel à propositions

H2020-SC1-PHE-CORONAVIRUS-2020-2

Voir d’autres projets de cet appel

Sous appel

H2020-SC1-PHE-CORONAVIRUS-2020-2-NMBP

Régime de financement

IA - Innovation action

Coordinateur

ETHNICON METSOVION POLYTECHNION
Contribution nette de l'UE
€ 658 625,00
Adresse
HEROON POLYTECHNIOU 9 ZOGRAPHOU CAMPUS
157 80 ATHINA
Grèce

Voir sur la carte

Région
Αττική Aττική Κεντρικός Τομέας Αθηνών
Type d’activité
Higher or Secondary Education Establishments
Liens
Coût total
€ 658 625,00

Participants (20)